(Updated - March 12, 2025 4:39 PM EDT)

Chardan Capital Markets analyst Danill Gataulin upgraded CervoMed (NASDAQ: CRVO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE